Skip to main content
. 2025 Aug 21;44:304. doi: 10.1186/s41043-025-01041-8

Table 2.

Overall comparison between the two treatment groups with respect to follow-up HbA1c, serum creatinine and eGFR levels

Glycated Hemoglobin (%)
Treatment Groups N Mean Rank U Statistic p-value*
Sitagliptin add-on Metformin 79 73.95 2682 0.25
Empagliflozin add-on Metformin 76 82.21
Serum Creatinine (mg/dl)
Treatment Groups N Mean Rank U Statistic p-value*
Sitagliptin add-on Metformin 79 65.9 2043 < 0.001
Empagliflozin add-on Metformin 76 90.6
eGFR (ml/min/1.73 m2)
Treatment Groups N Mean Rank U Statistic p-value
Sitagliptin add-on Metformin 79 81.1 2756.5 0.4
Empagliflozin add-on Metformin 76 74.8

*p-value was calculated using Mann-Whitney U test